Thymosin Alpha-1 Side Effects
Thymosin Alpha-1 is an immune-modulating peptide with a long clinical track record internationally. It is generally well-tolerated, with effects usually limited to the injection site.
When they appear & how long they last
Reported effects are mild, mostly local, and not cycle-dependent in a pronounced way. Immune-modulation effects are subtle by design.
Commonly reported Thymosin Alpha-1 side effects
The most common effect - local redness or soreness.
Mild, reported by some users.
Occasional, reflecting immune activity.
When to contact your provider
- Injection-site infection signs
- Allergic-reaction signs
- Any significant change in immune-related symptoms (especially with an autoimmune condition - clear with a provider first)
Biomarkers worth tracking on Thymosin Alpha-1
These catch issues early - before you feel them. Pull a baseline before you start, then re-check on the cadence noted below.
How to actually track Thymosin Alpha-1 side effects
Thymosin Alpha-1 is most useful to track via the immune outcome you are targeting (frequency of illness, recovery) plus a CBC/WBC and hs-CRP at baseline and end-of-cycle. If you have an autoimmune condition, that tracking matters more - and the compound is a provider conversation first.
Track Thymosin Alpha-1 with MyProtocolStack →